TXG 10x Genomics, Inc. Class A Common Stock Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Sources
YouTube
Twitter
Reddit
Substack
Insider
Loading...
0 selected
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
16:26
Jul 09
TXG had a strong double-digit day after the author noted volume ramping up and a major diagonal breakout, but no position is stated.
TXG
LOW
19:32
Jul 06
Buy TXG as a technical breakout (diagonal breakout, rising volume) combines with a fundamental dislocation — stock is down 80% from ATH while revenue and financials are improving, suggesting significant mispricing.
TXG 1ST
MED
09:04
Jun 10
__con_ Stock & Crypto Analyst
The author presents a large diversified basket of favorite names across sectors as where they are positioned for the next few years, but the 30+ tickers default to watch due to the basket size rule.
TXG
17:37
Jun 09
__con_ Stock & Crypto Analyst
Author discloses current positioning in TXG as a Health name, framing the dip as a buying opportunity with a multi-year hold thesis.
TXG 1ST
MED
13:19
Feb 06
Keith McCullough Founder & CEO, Hedgeye Risk Management
Buy TXG on the open per internal team recommendation; active buy signal triggered pre-market with explicit instruction to add to position.
TXG 1ST
MED

About TXG Analyst Coverage

Buzzberg tracks TXG (10x Genomics, Inc. Class A Common Stock) across 3 sources. 3 bullish vs 0 bearish calls from 3 analysts. Sentiment: predominantly bullish (60%). 5 total trade ideas tracked. Past 7 days: 1 bullish, 1 watch. Latest voices: incomesharks, __con_, Keith McCullough.